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Abstract
The aim of our study was to assess asthma control
among asthmatics at a tertiary care setting in Karachi using
ACT questionnaire. The ACT questionnaire was filled by
known asthmatics in January 2007. A total of 150
questionnaires were filled of which, 61 (40%) were males and
89 (60%) females. Mean ACT score was 17.71 +/- 4.41.
Association between sex and asthma control was not
statistically significant. Significant association was seen with
asthma control and Ipratropium bromide inhaler. Asthma
control among patients at a tertiary care centre is moderate.
ACT can be used to follow patients in the hospital. 
Introduction
The global burden of asthma has reached an alarming
level to worry physicians as well as health policy makers around
the world. More than 300 million people worldwide suffer from
this chronic potentially disabling disease and this figure is
projected to rise by 50% every decade.1 Figures from other
South Asian countries have shown to be as high as 29.5%2 and
Pakistan may not be very different. Even though The
International Study of Asthma and Allergies in Childhood
(ISAAC) study mentioned a prevalence of 8% in Pakistani
paediatric population, under reporting and lack of sound
epidemiological data may mask the reality.3
Previously, the Global Initiative for Asthma (GINA)
guidelines classified severity of asthma by dividing into
subcategories based on the level of symptoms and airflow
limitation and its variability.4,5 However, it must be realized that
asthma severity involves both the severity of the underlying
disease and its responsiveness to treatment. Hence, according to
the updated GINA guidelines, assessing the severity alone is no
longer recommended but emphasis has shifted to periodic
assessment of asthma control.6
Literature highlights several tools currently in use to
specifically assess asthma control, on the basis of patients'
symptoms, rescue medication use and limitation of daily
activities in adults and children.7,8 Most commonly utilized in
clinical settings are the asthma control questionnaire (ACQ), the
asthma therapy assessment questionnaire (ATAQ) and the
asthma control test (ACT).7
Of all the control assessment tools, ACT questionnaire
is short, simple, comprising of 5 patient-based questions and
more importantly cost effective as it does not encompass
pulmonary function tests.9 Hence it is a promising assessment
tool for our clinical setting. The ACT has been proven reliable,
valid, and responsive to changes in asthma control over time in
patients new to the care of asthma specialists.10 Its results have
also been seen to be in concordance with specialists'
assessments based on spirometry.9,10
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To our knowledge no study in the medical literature
exists that assesses baseline control of asthma in Pakistan.
Hence, the aim of our study was to assess asthma control among
asthmatics at a tertiary care setting in Karachi using Asthma
control test (ACT) questionnaire. 
Patients, Method and Results
The Asthma Control Test (ACT) questionnaire was
filled by 150 patients who were known asthmatics. The
study was conducted at a tertiary care hospital during the
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Figure: Asthma Control Test.
month of January 2007. All individuals presenting to the
clinic with a previously established diagnosis of asthma
based on physicians' notes, pulmonary function tests and
reversibility of effect and were 12 years and above were
included. These participants were enrolled consecutively as
they presented to the out-patient clinic. Patients with acute
exacerbation or those below 12 years of age were excluded.
The questionnaire is shown in the figure.
The ACT questionnaires were filled by patients with
the help of a research medical officer (RMO). Written
informed consent was taken before administering the
questionnaire. The study was approved by the ethical
committee of Department of Medicine, AKUH.
SPSS 15.0 (copyright © SPSS Inc., 1989-2007) was
used for statistical analysis. Results were expressed as mean ±
standard deviation for all continuous variables and frequency
and percentages for categorical data. Chi square was applied
to assess association between different variables. P-value less
than 0.05 was considered as significant. 
A total of 150 questionnaires were filled regarding
control of Asthma from known asthmatics. Out of 150
participants 61 (40%) were males and 89 (60%) females.
Out of all participants, 62 (41%) had presented for the first
time with a pre-established diagnosis of Asthma whereas 89
(59%) patients were followed in the same clinic for
management of their disease. 
Mean score on the ACT was found to be 17.71 +/-
4.41 with mean score for males of 18.23+/-4.68 and for
females 17.35 +/- 4.2. ACT questionnaire categorizes the
asthma control into 3 categories depending upon scores, that
is, scores of <19, 20-24 and 25. In our study population,
participants falling in these categories were 93 (63%), 47
(31%) and 10 (6.7%) respectively. Association between sex
and asthma control was determined and was not statistically
significant (p < 0.25). 
While objectively assessing asthma control,
antiasthmatic medications used by participants were also
taken into account to determine their baseline control with
any particular medication and to direct the management.
Antiasthmatics used by the participants were calculated and
were found to be Salbutamol 93 (62.0%), Ipratropium
Bromide 20 (13.3%), Steroids 59 (39.3%), Montelukast 11
(7.3%), combination of beclomethasone +salbutamol
(ventide) 3 (2.0%), theophylline 11 (7.3%) and
antihistamines 6 (4.0%). 
Associations between asthma control and
antiasthmatic medications were determined (Table).
Significant association was seen with asthma control and
Ipratropium bromide inhaler (p <0.01).
Conclusion
Asthma control among patients at a tertiary care
centre is not adequate. Asthma Control Test Questionnaire
can be used to follow patients in the hospital. Validity and
Reliability studies need to be conducted on a wider scale as
with this small sample, asthma control could not be
correlated with the recommended therapy for Asthma. 
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Table: Association between baseline control of Asthma (by ACT
scoring) with different antasthmatics medications.
Total Scores Yes (%) No (%) p-value
Ventolin
1-19 59 (39.3) 34 (22.7)
20-24 27 (18.0) 20 (13.3) 0.68
25 7 (4.7) 3 (2.0)
Ipratropium Bromide
<19 19 (12.7) 74 (49.3)
20-24 1(0.7) 46 (30.7) <0.01
25 0(0.0) 10 (6.7)
Steroids
<19 36 (24.0) 57 (38.0)
20-24 18 (12.0) 29 (19.3) 0.77
25 5 (3.3) 5 (3.3)
Montelukast
<19 10 (6.7) 83 (55.3)
20-24 1 (0.7) 46 (30.7) 0.12
25 0 (0.0) 10 (6.7)
(Seretide) Beclomethasone + Salbutamol
<19 2 (1.3) 91 (60.7)
20-24 1 (0.7) 46 (30.7) 0.90
25 0 (0.0) 10 (6.7)
Theophylline
<19 10 (6.7) 83 (55.3)
20-24 1 (0.7) 46 (30.7) 0.12
25 0 (0.0) 10 (6.7)
Antihistamines
<19 3 (2.0) 90(60.0)
20-24 2 (1.3) 45 (30.0) 0.58
25 1 (0.7) 9 (6.0)
(Ventide) fluticasone + salmeterol
<19 35 (23.3) 58 (38.7)
20-24 12 (8.0) 35 (23.3) 0.24
25 2 (1.3) 8 (5.3)
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Abstract
Infection with dengue viruses produces a spectrum of
clinical illness ranging from a nonspecific viral syndrome to
severe and fatal haemorrhagic disease. Important risk factors
include the strain and serotype of the infecting virus, as well as
the age, immune status, and genetic predisposition of the
patient. The teaching point in this case study was Dengue fever
which occurred concomitantly with Hepatitis A and Hepatitis E
virus infection. 
Introduction
Jaundice follows due to a variety of causes including
hepatitis A, B, C, D, and E viral infections, alcohol abuse,
medications and toxins. Hepatitis E virus (HEV) and hepatitis A
virus (HAV) are endemic in South Asia.1 Dengue fever (DF) is
a mosquito-borne virus infection, caused by four distinct viruses
(serotypes 1 to 4) that are closely related antigenically. Dengue
virus serotype 3 is responsible for most of the DF cases in
Karachi, Pakistan.2 There is no treatment of Dengue fever (DF).
However, dengue fever shock syndrome requires a supportive
treatment.3
Case Report
A 17 year old girl was admitted in September 2007 with
jaundice for one month associated with fever for ten days and
altered consciousness since one day. There was no significant
past history. Patient had paracetamol and antimalarials for the
last ten days. On examination, she was jaundiced and drowsy;
Glasgow coma scale (GCS) was 8/15 with a pulse 108/min,
blood pressure 109/73 mm Hg and temperature of 102ºF.
Systemic examination was normal, besides a palpable spleen.
The labs on admission demonstrated a haemoglobin of 10
(range 11.1-14.5) gm/dl, haematocrit 34.3% (range 35.4-42.0),
white cell count 3.2 (range 2.0-10.0) with neutrophil 84%
(range 40-75), platelet 183 x109/L (range 150-400); malarial
parasite was not seen on film; prothrombin time (PT) 23 (range
10-15 seconds), activated plasma thrombin time (APTT) 38.4
sec(range 25-35 seconds), bilirubin 22 (range 0.25-1.0) mg/dl,
alanine transaminase (ALT) 330 (range 3-33) I.U/L, aspartate
transaminase (AST) 220 (range 18-32) I.U/L; alkaline
phosphatase (ALP) 518 (range 31-141) I.U/L, gamma
glutamate transaminase (GGT) 33 (range 1-37) I.U/L, sodium
127 (range 136-148) mmol/L, potassium 2.5 mg (range 3.6-5.0)
mmol/L, albumin 1.9 g/dl, serum amylase 125 (range 25-125)
U/L, lactic dehydrogenase (LDH) 705 mg, magnesium 1.8
(range 1.9-2.5) mg/dl. Plasmodium falciparum and Plasmodium
Viva were negative by immunochromatographic test (ICT)
detecting malaria antigen. She was admitted in intensive care
unit for grade III Hepatic encephalopathy and treated with IV
fluid and lactulose. She stabilized haemodynamically over next
two days and her WBC count reduced to 15.3, PT 27, ALT 59,
K 3.0 mmol/L. Patient recovered from Hepatic encephalopathy
after 4 days. Serology was positive for HEV and HAV IgM
antibodies. Hepatitis B virus s Antigen (HBsAg), Hepatitis B
core IgM, Hepatitis C virus antibody and HEV virus IgG were
negative. Her chest x-ray and abdominal ultrasound were
normal. Blood cultures were negative. Antinuclear antibody,
anti-smooth muscle antibody and anti-mitochondrial antibody
screen were negative but Coomb's test was positive. Serum
ceruloplasmin and Urinary copper were in the normal range.
She was discharged home after two days after being stabilized,
on steroids, proton pump inhibitor and folic acid for haemolytic
anemia. Patient’s serology for DF IgM was positive.
Discussion
In this case, the dengue infection occurred concurrently
while the patient was also suffering from HEV and HAV. Anti-
dengue IgM detectable by IgM antibody capture enzyme-linked
immunosorbent assay (MAC-ELISA) appears in half of the
patients with a primary infection while they are still febrile; in
the other half, it appears within 2-3 days of defervescence.4
Anti-dengue IgM levels are detectable in about 30% of patients
2 months after the onset of symptoms.5 In this case, also, dengue
fever was positive on repeating the test. This is a common
observation by physicians actively involved in the management
of patients with dengue fever.5 Symptoms and signs of dengue
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